An Overview on CALR and CSF3R Mutations and a Proposal for Revision of WHO Diagnostic Criteria for Myeloproliferative Neoplasms

Leukemia - United Kingdom
doi 10.1038/leu.2014.35
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epigenetics and Mutations in Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2011English

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Impact of the 2016 Revised WHO Criteria for Myeloproliferative Neoplasms, Unclassifiable: Comparison With the 2008 Version

American Journal of Hematology
Hematology
2017English

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Leukemia Research
Cancer ResearchOncologyHematology
2016English

SRSF2 Mutations in Myelodysplasia/Myeloproliferative Neoplasms

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

The PVSG/WHO Versus the Rotterdam European Clinical, Molecular and Pathological Diagnostic Criteria for the Classification of Myeloproliferative Disorders and Myeloproliferative Neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018

2019English

Mutations of ASXL1 Gene in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy